A medication review and deprescribing method for hospitalised older patients receiving multiple medications

Internal Medicine Journal

Volumn 46, Issue 1, 2016, Pages 35-42

  Mckean, M ^a   Pillans, P ^b   Scott, I A ^b,c  

^a IPSWICH HOSPITAL   (United Kingdom)

^b PRINCESS ALEXANDRA HOSPITAL   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Deprescribing; Medication; Older patient; Review

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTACID AGENT; BRONCHODILATING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CLINICAL ARTICLE; DECISION SUPPORT SYSTEM; DEPRESCRIPTION; DRUG WITHDRAWAL; EDUCATION PROGRAM; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MALE; MEDICATION THERAPY MANAGEMENT; PRESCRIPTION; PRIORITY JOURNAL; DRUG UTILIZATION REVIEW; HOSPITALIZATION; INAPPROPRIATE PRESCRIBING; PILOT STUDY; POLYPHARMACY; PREVENTION AND CONTROL; PROCEDURES; PROSPECTIVE STUDY; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DEPRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; HOSPITALIZATION; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; PATIENT DISCHARGE; PILOT PROJECTS; POLYPHARMACY; PROSPECTIVE STUDIES;

EID: 84969389729     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/imj.12906     Document Type: Article

References (33)

1. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007; 370: 185-91.
2. Goldberg R, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996; 14: 447-50.
3. Kalisch LM, Caughey GE, Barratt JD, Ramsay EN, Killer G, Gilbert AL et al. Prevalence of preventable medication-related hospitalizations in Australia: an opportunity to reduce harm. Int J Qual Health Care 2012; 24: 239-49.
4. de Vries EN, Ramrattan MA, Smorenburg SM, Gouma DJ, Boermeester MA. The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care 2008; 17: 216-23.
5. Wimmer BC, Dent E, Bell JS, Wiese MD, Chapman I, Johnell K et al. Medication regimen complexity and unplanned hospital readmissions in older people. Ann Pharmacother 2014; 48: 1120-8.
6. Betteridge TM, Frampton CM, Jardine DL. Polypharmacy-we make it worse! A cross-sectional study from an acute admissions unit. Intern Med J 2012; 42: 208-11.
7. Hubbard RE, Peel NM, Scott IA, Martin JH, Smith A, Pillans PI et al. Polypharmacy among inpatients aged 70years or older in Australia. Med J Aust 2015; 202: 373-7.
8. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. Implications for pay for performance. JAMA 2005; 294: 716-24.
9. Tinetti M, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351: 2870-4.
10. Steinman MA, Miao Y, Boscardin WJ, Komaiko KD, Schwartz JB. Prescribing quality in older veterans: a multifocal approach. J Gen Intern Med 2014; 29: 1379-86.
11. Scott IA, Gray LA, Martin JH, Pillans PI, Mitchell CA. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evidence-Based Med 2013; 18: 121-4.
12. Scott IA, Hilmer SN, Reeve E, Potter K, Le Couteur D, Rigby D et al. Reducing inappropriate polypharmacy-the process of deprescribing. JAMA Intern Med 2015; 175: 827-34.
13. Scott IA, Martin JH, Gray LA, Mitchell CA. Effects of a drug minimisation guide on prescribing intentions in elderly persons with polypharmacy. Drugs Ageing 2012; 29: 659-67.
14. Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open 2014; 4: e006544.
15. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173: 489-95.
16. Moss AH, Lunney JR, Culp S, Auber M, Kurian S, Rogers J et al. Prognostic significance of the 'surprise' question in cancer patients. J Palliat Med 2010; 13: 837-40.
17. Carey EC, Covinsky KE, Lui L, Eng C, Sands LP, Walter LC. Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc 2008; 56: 68-75.
18. Finch A, McKean M, Pillans P, Scott I. Pilot study of a drug minimisation guide applied to older patients in hospital. Proceedings of Australian Society of Clinical and Experimental Pharmacologists and Toxicologists Annual Scientific Meeting. Melbourne, 1-4 December 2013; p. 45.
19. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007; 9: 430-4
20. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med 2010; 170: 1648-54.
21. Mudge A, Radnedge K, Kasper K, Mullins R, Adsett J, Rofail S et al. Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing. Aust Health Rev 2015. doi:10.1071/AH14219.
22. Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65years and older. Drugs Aging 2008; 25: 1021-31.
23. Pasina L, Nobili A, Tettamanti M, Salerno F, Corrao S, Marengoni A et al. Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly. Eur J Intern Med 2011; 22: 205-10.
24. Akram F, Huang Y, Lim V, Huggan PJ, Merchant RA. Proton pump inhibitors: are we still prescribing them without valid indications? Australas Med J 2014; 7: 465-70.
25. Corleto VD, Festa S, De Giulio E, Annibale B. Proton pump inhibitor therapy and potential long-term harm. Curr Opin Endocrinol Diabetes Obes 2014; 21: 3-8.
26. Odden MC, Pletcher MJ, Coxson PG, Thekkethala D, Guzman D, Heller D et al. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75years or older in the United States. Ann Intern Med 2015; 162: 533-41.
27. Russell BJ, Rowett D, Abernethy AP, Currow DC. Prescribing for comorbid disease in a palliative population: focus on the use of lipid-lowering medications. Intern Med J 2014; 44: 177-84.
28. Kutner JS, Blatchford PJ, Taylor DH, Ritchie CS, Bull JH, Fairclough DL et al. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness. A randomized clinical trial. JAMA Intern Med 2015; 175: 691-700.
29. Qi K, Reeve E, Hilmer SN, Pearson SA, Matthews S, Gnjidic D. Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. Int J Clin Pharm 2015; 37: 949-57.
30. Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education. The EMPOWER cluster randomized trial. JAMA Intern Med 2014; 174: 890-8.
31. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262: 3303-7.
32. Liu B, Anderson G, Mittmann N, To T, Axcell T, Shear N. Use of selective serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998; 351: 1303-7.
33. Scott IA, Le Couteur D. Physicians need to take the lead in deprescribing. Intern Med J 2015; 45: 352-6.